On August 11, 2020, Scioto Biosciences, Inc. closed the transaction. The company amended the terms of the transaction. The company will issue 31,547,619,047 common shares at an issue price $0.00084 per share for the gross proceeds of $26,500,000. The transaction was led by new investor Genome & Company (XKON:A314130) and included participation from other investors.